Instructions to Authors

The publication, diffusion, and furtherance of research and study on all aspects of Bacteriology, Virology and related fields (Mycology and Parasitology) are the chief aims of New Microbiologica.
New Microbiologica will publish editorials, minireviews, full-length papers, short communications, and case reports relating to all aspects of Microbiology and Infectious Diseases.
Manuscripts submitted to New Microbiologica must constitute original research reports. All authors must have agreed to the submission of a manuscript and are responsible for its content. The corresponding author is responsible for obtaining such agreement and for informing the coauthors of the manuscript’s status throughout the submission, review, and publication process. By submission of a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, is not being considered or published elsewhere. By publishing in New Microbiologica, the authors agree that any virus, plasmids, and other materials such as microbial strains and cell lines newly described in the article are available at reasonable cost to members of the scientific community for noncommercial purposes.

New Microbiologica publishes editorials, reviews, full-length papers, short communications, and case reports relating to all aspects of Bacteriology, Virology, and Infectious Diseases.

Editorials: Editorials are intended to offer the opportunity to present in brief form (1000 words maximum; up to 15 references; 5-10 key words; abstract up to 100 words) the opinion of the editors or editorial board on recent topics related to all fields of Microbiology, Virology, and Infectious Diseases.
Reviews: Reviews are expected to be focused discussions of defined topics relevant to microbiologists. In general, reviews are invited by the Editors. Authors wishing to submit a review should contact the editorial office to provide a potential title and subject. Minireviews that are proffered by authors are subject to editorial review.
Full-Length Papers: Full-length papers should be divided into sections with appropriate headings. Their sequence should be as follows: Title page, Summary, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References.
Short Communications: Short Communications are intended to offer the opportunity to present in brief form noteworthy results of work in progress or technical advancements. Their length should not exceed eight pages of double-spaced typescript. They should not contain more than two tables or two figures or one table and one figure. Materials and methods should be described in the text, not in figure legends or table footnotes.
Short communications are not divided into sections, except for a short summary of not more than 100 words and acknowledgments and references. Acknowledgments should be presented as in full-length papers, but no separate heading is used. The References section is identical to that of full-length papers. Short Communications receive the same review process. They are not published more rapidly than full-length papers and are not considered preliminary communications.
Case Reports: Short articles of a clinical nature which illustrate or illuminate an underlying principle of a disease state, its diagnosis, or its therapy

Manuscript Submission

The editors encourage authors to submit manuscripts by e-mail as an attachment in Word or Rich Text Format to:
E-mailed manuscripts must be in A4 format, Times New Roman 12 point font, justified, and one and a half line-spaced.
Figure file formats: Figures must be submitted as separate files. Acceptable file formats are JPEG or TIFF. Please note that files saved in TIFF format from within the PowerPoint application are NOT suitable quality for publication.
Non-standard characters (Greek letters, mathematical symbols, etc.) should be coded consistently throughout the text. Please make a list of such characters and provide a listing of the codes used.
Processing Charge: New Microbiologica levies an article-processing charge for every accepted article, to cover the costs for publication. All accepted articles will be available online Starting from 2022, the article-processing charge is 100,00 euro/printed page.

Organization and format

Title page

Should include a title, the name(s) of all author(s) (first name, middle initial and last name of each author), the affiliation, a running title (do not exceed 54 characters and spaces), and a footnote indicating (by asterisk) to whom correspondence should be sent (with the complete mailing address, a single telephone number, a single fax number, and a single e-mail address). This information will be published in the article as a footnote to facilitate communication, and the e-mail address will be used to notify the corresponding author of availability of proofs and, later, of the PDF file of the published article.


The introduction should supply sufficient background information to allow the reader to understand and evaluate the results of the present study without referring to previous publications on the topic. The introduction should also provide the rationale for the study.


In the Results section, include the rationale or design of the experiments as well as the results; reserve interpretation of the results for the Discussion section. Present the results as concisely as possible.


The source of any financial support received for the work being published must be specified in the Acknowledgments section.


The abstract will be published separately by abstracting services and should be complete and understandable without reference to the text. Limit the abstract to 200 words or fewer and concisely summarize the basic content of the paper without presenting extensive experimental details.

Key words

Key words (3-6) should be provided at the foot of the summary.

Materials and Methods

The Materials and Methods section must include sufficient technical information to allow the experiments to be repeated. The sources of all media (i.e., name and location of manufacturer) or components of a new formulation must be provided.


The Discussion section should provide an interpretation of the results in relation to previously published work and to the experimental system at hand. It must not contain extensive repetition of the Results section or reiteration of the introduction. In short papers, the Results and Discussion sections may be combined.


In the text, a reference should be cited by author and date and enclosed by round brackets, e.g.: “King (2003) reported that… (King, 2003; White et al., 2005)…”; not more than two authors may be cited per reference; if there are more than two authors use et al. More than one paper from the same author in the same year must be identified by the letters a, b, c, etc., placed after the year of publication.
Reference section. References must NOT be numbered. Arrange the citations in alphabetical order by first author.All authors should be included in reference lists unless there are more than five, in which case only the first five authors should be given, followed by ‘et al.’. Each reference begins with the names of the authors and the year of publication. For references to journals give titles of articles in full, inclusive pagination, and journal titles. For references to books, include all author’s names, chapter titles (if any), editor (if any), book title, city of publication, publisher’s name, and year of publication.

Note the following example: Re MC, Bon I, Grandi N, Miserocchi A, Morini S, Clò A, Furlini G, Gibellini D. (2012). Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. New Microbiol. 35:407-414

Click here to download the EndNote Output Style.

Use of Human Subjects or Animals in Research

Manuscripts containing information related to human or animal use should clearly state that the research has complied with all relevant international guidelines and institutional policies. Copies of these guidelines and policy statements must be available for review by the editor if necessary.

Patient Identification

To protect the privacy of individuals mentioned in clinical studies or case histories and as sources of isolates, do not identify them by their initials, even as part of a strain designation. Change the initials to numerals or use randomly chosen letters. Do not give hospital unit numbers; if a designation is needed, use only the last two digits of the unit.

Nucleotide and Amino Acid Sequences

It is expected that newly determined nucleotide and/or amino acid sequence data will be registered and GenBank/EMBL/DDBJ accession numbers be included in the manuscript no later than the modification stage of the review process. It is also expected that the sequence data will be released to the public no later than the publication date of the article.
The accession number should be included in a separate paragraph at the end of the Materials and Methods section for full-length papers or at the end of the text for Notes. If conclusions in a manuscript are based on the analysis of sequences and a GenBank/EMBL/DDBJ accession number is not provided at the time of review, authors should provide the sequence data as supplementary material.
It is expected that, when previously published sequence accession numbers are cited in a manuscript, the original citations (e.g., journal articles) will be included in the References section when possible or reasonable.